SBBP - Strongbridge Biopharma plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue18,0277,046--
Cost of Revenue3,9861,483--
Gross Profit14,0415,563--
Operating Expenses
Research Development25,44117,26820,02320,135
Selling General and Administrative63,33636,29214,87519,329
Non Recurring----
Others----
Total Operating Expenses99,95060,06534,89839,464
Operating Income or Loss-81,923-53,019-34,898-39,464
Income from Continuing Operations
Total Other Income/Expenses Net114,310-58,693-16,459-4,619
Earnings Before Interest and Taxes-81,923-53,019-34,898-39,464
Interest Expense-12,515-4,313-20-20
Income Before Tax32,387-111,712-51,357-44,083
Income Tax Expense5361,771-2,638-450
Minority Interest---564
Net Income From Continuing Ops31,851-113,483-48,719-43,633
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income31,851-113,483-48,597-43,580
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares31,851-113,483-48,597-43,580